Clin2
NCT07165210Possibly a fitRecruiting

Lymph node spread in esophageal cancer trial

Esophageal Cancer

Part of Cancer, Digestive system clinical trials.

This trial looks at how often a specific lymph node (106TBL) is involved in esophageal squamous cell carcinoma. It may help guide treatment decisions for people who have not had other cancers and whose tumor is in the chest (not the neck).

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,852 people
Ages
20 years to 85 years
Study type
Observational

Who can take part

  • You have squamous cell carcinoma of the esophagus.
  • Your cancer is stage cT1-4a N0 or N+ and has not spread to other organs (M0).
  • You have not had any other cancer before.
  • Your tumor is not in the neck area.
  • You are healthy enough to have surgery to remove your esophagus.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07165184Recruiting
Lymph node spread in esophageal cancer study

This study looks at how often cancer has spread to lymph nodes in people with esophageal squamous cell carcinoma. It may help doctors plan better treatment. You may be eligible if your cancer hasn't spread to other organs and you haven't had another cancer.

Shanghai, Shanghai Municipality
NCT06161818Recruiting· Phase 2
Combined therapy before surgery for lymph node-positive esophageal cancer

This trial is testing a combination of chemotherapy and radiation (called total neoadjuvant therapy) before surgery for a type of esophageal cancer that has spread to lymph nodes. The goal is to see if this approach improves outcomes.

Eindhoven, North Brabant
NCT06914011Not yet recruiting· Phase 3
Adjuvant chemotherapy for esophageal cancer guided by blood test

This trial tests whether giving chemotherapy after surgery, based on a blood test that finds tiny bits of cancer DNA, can improve outcomes for people with esophageal squamous cell carcinoma. The blood test helps decide who might benefit from extra treatment.

NCT06979986Not yet recruiting
Comparing lymph node surgery after endoscopic removal for early esophageal cancer

This trial compares two ways of managing early-stage esophageal cancer after it has been removed through an endoscope: one group has lymph nodes removed (surgery), the other does not. It aims to find out if skipping lymph node removal is safe and effective.

NCT06558786Recruiting
Registry for esophageal cancer that has spread to a few spots

This study tracks patients with stage IV esophageal or gastroesophageal junction cancer that has spread to only a limited number of places (like the liver, lung, or a few lymph nodes). The goal is to understand how well treatments like surgery or radiation work after initial drug therapy.

New York, New York
NCT06122493Recruiting· Phase 2
Better treatment for advanced esophageal cancer

This trial tests a new treatment plan for people with advanced esophageal squamous cell carcinoma that has spread to lymph nodes but not to other organs. It aims to find the best way to treat this cancer using radiation and other therapies.

Shanghai, Shanghai Municipality

Hear when a new Esophageal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.